<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">oncotomsk</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский онкологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Siberian journal of oncology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1814-4861</issn><issn pub-type="epub">2312-3168</issn><publisher><publisher-name>Tomsk National Research Medical Сепtеr of the Russian Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21294/1814-4861-2020-19-5-82-87</article-id><article-id custom-type="elpub" pub-id-type="custom">oncotomsk-1582</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОПЫТ РАБОТЫ ОНКОЛОГИЧЕСКИХ УЧРЕЖДЕНИЙ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ONCOLOGY PRACTICE</subject></subj-group></article-categories><title-group><article-title>РЕЗЕКЦИЯ АРТЕРИЙ В ХИРУРГИИ РАКА ПОДЖЕЛУДОЧНОЙ ЖЕЛЕЗЫ: ОПЫТ ОДНОГО УЧРЕЖДЕНИЯ</article-title><trans-title-group xml:lang="en"><trans-title>ARTERIAL RESECTION IN PANCREATIC CANCER SURGERY: A SINGLE-CENTER EXPERIENC</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чичеватов</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Сhichevatov</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, заведующий кафедрой онкологии и урологии,</p><p>440060, г. Пенза, ул. Стасова 8А</p></bio><bio xml:lang="en"><p>MD, DSc, Head of the Department of Oncology and Urology, </p><p>8A, Stasova Street, 440060, Penza</p></bio><email xlink:type="simple">chichevatov69@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Калентьев</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kalentev</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач хирургического отделения № 2,</p><p>440066, г. Пенза, пр. Строителей 37а</p></bio><bio xml:lang="en"><p>MD, Physician, Surgical Department № 2, </p><p>37A, Prospect Stroiteley, 440066</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Глухов</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Glukhov</surname><given-names>A. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант кафедры онкологии и урологии,</p><p>440060, г. Пенза, ул. Стасова 8А</p></bio><bio xml:lang="en"><p>MD, Postgraduate, Department of Oncology and Urology,</p><p>8A, Stasova Street, 440060, Penza</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Пензенский институт усовершенствования врачей – филиал ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Penza Institute for Further Training of Physicians – branch of the Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБУЗ «Областной онкологический диспансер»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Regional Oncology Health Center</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>28</day><month>10</month><year>2020</year></pub-date><volume>19</volume><issue>5</issue><fpage>82</fpage><lpage>87</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Чичеватов Д.А., Калентьев В.В., Глухов А.Е., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Чичеватов Д.А., Калентьев В.В., Глухов А.Е.</copyright-holder><copyright-holder xml:lang="en">Сhichevatov D.A., Kalentev V.V., Glukhov A.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.siboncoj.ru/jour/article/view/1582">https://www.siboncoj.ru/jour/article/view/1582</self-uri><abstract><p>Панкреатодуоденальная резекция (ПДР) с пластикой сосудов по поводу рака поджелудочной железы выполняется примерно в 20 % случаев. В то время как резекция и пластика верхней брыжеечной вены является рутинно выполняемой операцией, целесообразность резекции артерий при ПДР остается предметом дискуссии.</p><p>Цель исследования – оценить непосредственные и отдаленные результаты выполнения панкреатодуоденальных резекций с пластикой различных артерий.</p><sec><title>Материал и методы</title><p>Материал и методы. Проанализированы результаты 89 панкреатодуоденальных резекций и панкреатодуоденэктомий, выполненных по поводу злокачественных опухолей периампулярной локализации II–IV стадий. Средний возраст пациентов составил 63,1 ± 8,2 года. Ангиопластических операций было 18 (20,2 %), из них 7 артериопластик.</p></sec><sec><title>Результаты и обсуждение</title><p>Результаты и обсуждение. В группе пациентов (n=7), перенесших резекцию артерии, послеоперационные осложнения развились в 5 (71,4 %) случаях, у 71 больного, которым выполнялись ПДР без пластики артерии и/или вены, осложнения возникли в 29 (40,8 %) наблюдениях (р=0,229). Послеоперационная летальность составила 1 (14,3 %) и 3 (4,2 %) случая соответственно (р=0,319). Медиана безрецидивной выживаемости при артериопластических операциях составила 5,0 мес (95 % ДИ 2,4–7,6 мес), при стандартных вмешательствах – 12,3 мес (95 % ДИ 9,2–15,4 мес) (log-rank test, p=0,011); медиана общей выживаемости – 8,0 мес (95 % ДИ 3,7–12,3 мес) и 21,8 мес (95 % ДИ 15,9–27,7 мес) (log-rank test, p=0,011).</p></sec><sec><title>Выводы</title><p>Выводы. Показатели безрецидивной и общей выживаемости значимо хуже при панкреатодуоденальных резекциях с артериопластикой, что, возможно, связано с малой выборкой пациентов. Необходимо проведение масштабных исследований с целью изучения непосредственной и отдаленной эффективности ПДР с ангиопластическим компонентом, выполненных по поводу злокачественных новообразований поджелудочной железы. </p></sec></abstract><trans-abstract xml:lang="en"><p>Pancreaticoduodenal resection (PDR) with vascular reconstruction is performed in approximately 20 % of pancreatic cancer patients. The superior mesenteric vein resection and reconstruction has become a standard routine surgery, whereas arterial resection during pancreatic surgery is still an issue of controversial debate.</p><p>The purpose of the study was to evaluate short-and long-term outcomes of PDR with reconstruction of various arteries.</p><sec><title>Material and Methods</title><p>Material and Methods. Outcomes of 89 PDRs and pancreaticoduodenectomies performed in patients with stage II–IV periampullary carcinoma were assessed. The average age of the patients was 63.1 ± 8.2. There were 18 (20.2 %) PDRs with vascular reconstruction, of them 7 (7.8 %) were arterial resections.</p></sec><sec><title>Results</title><p>Results. In patients who underwent artery resection (n=7), complications were observed in 5 (71.4 %) cases. Out of 71 patients who underwent PDR without arterial and/or venous resection, 29 (40.8 %) had complications (p=0.229). The postoperative mortality rates were 1 (14.3 %) and 3 (4.2 %), respectively (p=0.319). The median disease-free survival was 5.0 months (95 % CI 2.4–7.6 months) in the arterial resection group and 12.3 months (95 % CI 9.2–15.4 months) in the standard surgery group (log-rank test, p=0,011). The median overall survival was 8.0 months (95 % CI 3.7–12.3 months) in the in the arterial resection group and 21.8 months (95 % CI 15.9–27.7 months) in the standard surgery group (log-rank test, p=0.011).</p></sec><sec><title>Conclusion</title><p>Conclusion. The disease-free and overall survival rates were significantly worse in the arterial resection group than in the standard surgery group. This is most likely due to a small sample of patients. Further studies are needed to analyze the immediate and long-term treatment outcomes of PDR with arterial resection for pancreatic cancer. </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>рак поджелудочной железы</kwd><kwd>панкреатоэктомия</kwd><kwd>панкреатодуоденальная резекция</kwd><kwd>резекция артерии</kwd><kwd>ангиопластика</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pancreatic cancer</kwd><kwd>pancreatectomy</kwd><kwd>pancreaticoduodenal resection</kwd><kwd>arterial resection</kwd><kwd>vascular reconstruction</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Hackert T., Schneider L., Büchler M.W. Current State of Vascular Resections in Pancreatic Cancer Surgery. Gastroenterol Res Pract. 2015; 2015: 120207. doi: 10.1155/2015/120207.</mixed-citation><mixed-citation xml:lang="en">Hackert T., Schneider L., Büchler M.W. Current State of Vascular Resections in Pancreatic Cancer Surgery. Gastroenterol Res Pract. 2015; 2015: 120207. doi: 10.1155/2015/120207.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Marangoni G., O’Sullivan A., Faraj W., Heaton N., Rela M. Pancreatectomy with synchronous vascular resection--an argument in favour. Surgeon. 2012 Apr; 10(2): 102–6. doi: 10.1016/j.surge.2011.12.001.</mixed-citation><mixed-citation xml:lang="en">Marangoni G., O’Sullivan A., Faraj W., Heaton N., Rela M. Pancreatectomy with synchronous vascular resection--an argument in favour. Surgeon. 2012 Apr; 10(2): 102–6. doi: 10.1016/j.surge.2011.12.001.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Klaiber U., Mihaljevic A., Hackert T. Radical pancreatic cancer surgery-with arterial resection. Transl Gastroenterol Hepatol. 2019 Feb 3; 4: 8. doi: 10.21037/tgh.2019.01.07.</mixed-citation><mixed-citation xml:lang="en">Klaiber U., Mihaljevic A., Hackert T. Radical pancreatic cancer surgery-with arterial resection. Transl Gastroenterol Hepatol. 2019 Feb 3; 4: 8. doi: 10.21037/tgh.2019.01.07.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Jegatheeswaran S., Baltatzis M., Jamdar S., Siriwardena A.K. Superior mesenteric artery (SMA) resection during pancreatectomy for malignant disease of the pancreas: a systematic review. HPB (Oxford). 2017 Jun; 19(6): 483–490. doi: 10.1016/j.hpb.2017.02.437.</mixed-citation><mixed-citation xml:lang="en">Jegatheeswaran S., Baltatzis M., Jamdar S., Siriwardena A.K. Superior mesenteric artery (SMA) resection during pancreatectomy for malignant disease of the pancreas: a systematic review. HPB (Oxford). 2017 Jun; 19(6): 483–490. doi: 10.1016/j.hpb.2017.02.437.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Dunne D., Kleeff J., Yip V., Halloran C., Ghaneh P., Neoptolemos J. Arterial Resection in Pancreatic Cancer. Pancreatic Cancer. 2016 Jan: 1–16. doi: 10.1007/978-1-4939-6631-8_72-1.</mixed-citation><mixed-citation xml:lang="en">Dunne D., Kleeff J., Yip V., Halloran C., Ghaneh P., Neoptolemos J. Arterial Resection in Pancreatic Cancer. Pancreatic Cancer. 2016 Jan: 1–16. doi: 10.1007/978-1-4939-6631-8_72-1.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ho C.K., Kleeff J., Friess H., Büchler M.W. Complications of pancreatic surgery. HPB (Oxford). 2005; 7(2): 99–108. doi: 10.1080/13651820510028936.</mixed-citation><mixed-citation xml:lang="en">Ho C.K., Kleeff J., Friess H., Büchler M.W. Complications of pancreatic surgery. HPB (Oxford). 2005; 7(2): 99–108. doi: 10.1080/13651820510028936.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Gong Y., Zhang L., He T., Ding J., Zhang H., Chen G., Zhang D., Wu Z., Chen Q., Fan H., Wang Q., Bie P., Wang H. Pancreaticoduodenectomy combined with vascular resection and reconstruction for patients with locally advanced pancreatic cancer: a multicenter, retrospective analysis. PLoS One. 2013 Aug 2; 8(8): e70340. doi: 10.1371/journal.pone.0070340.</mixed-citation><mixed-citation xml:lang="en">Gong Y., Zhang L., He T., Ding J., Zhang H., Chen G., Zhang D., Wu Z., Chen Q., Fan H., Wang Q., Bie P., Wang H. Pancreaticoduodenectomy combined with vascular resection and reconstruction for patients with locally advanced pancreatic cancer: a multicenter, retrospective analysis. PLoS One. 2013 Aug 2; 8(8): e70340. doi: 10.1371/journal.pone.0070340.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
